In silico validation of human N-myc downstream-regulated gene 2 protein against Alzheimer's disease using molecular modeling, docking and dynamics studies
Drug Invention Today · 2013
DOI: 10.1016/j.dit.2013.02.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Invention Today, 2013. Verfasst von Aathi Muthusankar und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Muthusankar, A., & Shanmughavel, P. (2013). In silico validation of human N-myc downstream-regulated gene 2 protein against Alzheimer's disease using molecular modeling, docking and dynamics studies. Drug Invention Today. https://doi.org/10.1016/j.dit.2013.02.002
Vancouver
Muthusankar A, Shanmughavel P. In silico validation of human N-myc downstream-regulated gene 2 protein against Alzheimer's disease using molecular modeling, docking and dynamics studies. Drug Invention Today. 2013. doi:10.1016/j.dit.2013.02.002
BibTeX
@article{Muthusankar2013,
author = {Muthusankar, Aathi and Shanmughavel, Piramanayagam},
title = {In silico validation of human N-myc downstream-regulated gene 2 protein against Alzheimer's disease using molecular modeling, docking and dynamics studies},
journal = {Drug Invention Today},
year = {2013},
doi = {10.1016/j.dit.2013.02.002}
}
EUVIMED